英博博士（Dr. Bo Ying）
艾博生物创始人、董事长兼首席执行官
Founder, Chairman and CEO of Abogen Biosciences
英博博士是艾博生物创始人、董事长兼首席执行官。自2019年创立以来，艾博生物迅速成长为中国mRNA药物治疗领域的领军企业，建立起具有自主知识产权的mRNA平台，发展先进的递送技术，专注于治疗传染病、自身免疫性疾病以及癌症。
英博士本科及硕士均毕业于复旦大学，后于美国波士顿东北大学获得药剂学博士学位。他是多项海外授权专利的发明人，在Cell、The Lancet等国际顶级学术期刊发表多篇研究成果。
Dr. Bo Ying is the founder, chairman, and CEO of Abogen Biosciences, a leading mRNA therapeutic company in China. Since 2019, Abogen has established a proprietary mRNA platform and advanced delivery technologies for the treatment of infectious diseases, autoimmune diseases as well as cancer.
Dr. Ying obtained his bachelor and master degrees at Fudan University and a Ph.D. in Pharmaceutical Sciences from Northeastern University in Boston. He is also the inventor of multiple innovative technologies, and his research work has been published in Cell and The Lancet.
艾博生物创始人、董事长兼首席执行官
Founder, Chairman and CEO of Abogen Biosciences
英博博士是艾博生物创始人、董事长兼首席执行官。自2019年创立以来，艾博生物迅速成长为中国mRNA药物治疗领域的领军企业，建立起具有自主知识产权的mRNA平台，发展先进的递送技术，专注于治疗传染病、自身免疫性疾病以及癌症。
英博士本科及硕士均毕业于复旦大学，后于美国波士顿东北大学获得药剂学博士学位。他是多项海外授权专利的发明人，在Cell、The Lancet等国际顶级学术期刊发表多篇研究成果。
Dr. Bo Ying is the founder, chairman, and CEO of Abogen Biosciences, a leading mRNA therapeutic company in China. Since 2019, Abogen has established a proprietary mRNA platform and advanced delivery technologies for the treatment of infectious diseases, autoimmune diseases as well as cancer.
Dr. Ying obtained his bachelor and master degrees at Fudan University and a Ph.D. in Pharmaceutical Sciences from Northeastern University in Boston. He is also the inventor of multiple innovative technologies, and his research work has been published in Cell and The Lancet.
